Christine A. Nash is SVP & Chief Commercial Officer at HYPERION THERAPEUTICS INC (HPTX). They have made 1 open-market trade across 1 company since 2014, most recently 2015-05-07.
CIK 0001554403
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HPTX | 65,869 | — |
Shares reported on the most recent Form 4, priced at the 2015-05-05 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HPTX | SELL · 10b5-1 | 2015-03-17 | 2015-03-17 | $37.56 | $376K | N/A | N/A | N/A |
| HPTX | SELL · 10b5-1 | 2015-03-10 | 2015-03-13 | $35.08 | $351K | N/A | N/A | N/A |
| HPTX | SELL · 10b5-1 | 2015-03-09 | 2015-03-10 | $29.63 | $293K | N/A | N/A | N/A |
| HPTX | SELL · 10b5-1 | 2015-01-20 | 2015-01-22 | $24.82 | $124K | N/A | N/A | N/A |
| HPTX | SELL · 10b5-1 | 2014-03-06 | 2014-03-10 | $29.05 | $148K | N/A | N/A | N/A |
| HPTX | SELL | 2014-01-10 | 2014-01-14 | $24.09 | $241K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.